ImpediMed Announces Ambitious New Program Aimed at Ending Cancer-Related Lymphedema

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. MRK
5. MRNA
6. LOW
7. ADI
8. COTY
9. RARE
10. TJX

Go back to ImpediMed Announces Ambitious New Program Aimed at Ending Cancer-Related Lymphedema
SPDR S&P INTERNATIONAL CONSUMER DISCRETIONARY SECTOR (NYSE: IPD) Delayed: 39.92 --0 (-0%)
Previous Close $39.92    52 Week High $38.41 
Open $20.59    52 Week Low $31.52 
Day High $39.92    P/E N/A 
Day Low $39.92    EPS $0.00 
Volume 16,495